ImmunoPET: concept, design, and applications

W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Progress and future trends in PET/CT and PET/MRI molecular imaging approaches for breast cancer

Y Ming, N Wu, T Qian, X Li, DQ Wan, C Li, Y Li… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …

HER-2-targeted nanoparticles for breast cancer diagnosis and treatment

L Sitia, M Sevieri, L Signati, A Bonizzi, A Chesi… - Cancers, 2022 - mdpi.com
Simple Summary Despite tremendous efforts in finding new therapeutic strategies and
promoting screening programs to increase early diagnosis, breast cancer is still a major …

PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells

S Xu, F Cui, D Huang, D Zhang, A Zhu… - International journal …, 2019 - Taylor & Francis
Background Docetaxel (DOC) is widely used as a chemotherapy drug for various tumors,
including gastric cancer (GC), but the clinical application of DOC has been limited due to the …

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target

J De Vos, N Devoogdt, T Lahoutte… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Molecular imaging is a fast developing field and there is a growing need for
specific imaging tracers in the clinic. Camelid single-domain antibody-fragments (sdAbs) …

A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery

Y Liu, K Li, B Liu, SS Feng - Biomaterials, 2010 - Elsevier
Research on quantitative control of targeting effect for the drug delivery system of ligand-
conjugated nanoparticles of biodegradable polymers is at the cutting edge in the design of …

Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody …

G Wozniak-Knopp, S Bartl, A Bauer… - … , Design & Selection, 2010 - academic.oup.com
Yeast surface display libraries of human IgG1 Fc regions were prepared in which loop
sequences at the C-terminal tip of the CH3 domain were randomized. A high percentage of …

Non‐invasive molecular imaging for preclinical cancer therapeutic development

AC O'farrell, SD Shnyder, G Marston… - British journal of …, 2013 - Wiley Online Library
Molecular and non‐invasive imaging are rapidly emerging fields in preclinical cancer drug
discovery. This is driven by the need to develop more efficacious and safer treatments, the …

[HTML][HTML] Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals

M Morais, MT Ma - Drug Discovery Today: Technologies, 2018 - Elsevier
Antibodies and their derivatives radiolabelled with positron-and gamma-emitting
radiometals enable sensitive and quantitative molecular Positron Emission Tomography …

Engineering of affibody molecules for therapy and diagnostics

J Feldwisch, V Tolmachev - Therapeutic Proteins: Methods and Protocols, 2012 - Springer
Affibody molecules are small and robust non-immunoglobulin affinity ligands capable of
binding to a wide range of protein targets. They are selected from combinatorial libraries …